Safety of intravenous immunoglobulin and plasma exchange in critically ill patients

Neurological Research
Sarah L Clark, Alejandro A Rabinstein

Abstract

To assess the safety profile of intravenous immunoglobulin (IVIG) and plasma exchange (PLEX) when used to treat critically ill patients. We performed a retrospective analysis of consecutive patients who received IVIG or PLEX while admitted to our medical intensive care unit (ICU), neuroscience ICU or haematologic/oncologic ICU between 2007 and 2011.Patients who were transferred into an ICU while receiving therapy or who continued therapy after discharge from the ICU were included in the analysis. A total of 118 consecutive patients were included in the study. Fifty-nine patients received IVIG. Twenty of these patients (34%) developed renal failure during the hospitalisation, including 15 (25.4%) in whom renal function worsened during or shortly after IVIG administration and 4 (6.8%) in whom IVIG was considered a possible cause. Transfusion reactions occurred in five patients (8%). Seven patients (12%) did not receive the full intended course of IVIG. Thirty-four patients (58%) who received IVIG died during their hospitalisation. Fifty-nine patients received PLEX. Hypotension requiring an intervention was noted with 39 sessions (8.5%) and led to discontinuation of the session in 11 (2.4%). Other adverse events included line-rela...Continue Reading

References

May 8, 2002·BMJ : British Medical Journal·Scott Gottlieb
Jun 11, 2003·Neurology·Darin OkudaKumaraswamy Sivakumar
Aug 20, 2003·Archives of Dermatology·Kenneth A KatzVictoria P Werth
Aug 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Rinaldo BellomoUNKNOWN Acute Dialysis Quality Initiative workgroup
Mar 26, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sachin Shah, Marne Vervan
May 10, 2005·Journal of Clinical Apheresis·Jeffrey L Winters
Jun 23, 2005·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Daphna ParanRonen Ben-Ami
Aug 16, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sachin Shah
Apr 4, 2006·The Journal of Allergy and Clinical Immunology·Jordan S OrangeUNKNOWN Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
Sep 8, 2006·Clinical Medicine : Journal of the Royal College of Physicians of London·T El-ShanawanyStephen Jolles
Apr 3, 2007·Transfusion Medicine Reviews·Paula RobinsonUNKNOWN IVIG Hematology and Neurology Expert Panels
Aug 31, 2007·Journal of Korean Medical Science·Yu Ji LeeWon Ki Kang
Sep 7, 2007·Neurocritical Care·Farrah Jasmine Mateen, Dennis Gastineau
Nov 4, 2009·Clinical and Experimental Immunology·H-P HartungS Jolles
Jun 23, 2010·Journal of Clinical Apheresis·Zbigniew M SzczepiorkowskiUNKNOWN Apheresis Applications Committee of the American Society for Apheresis
May 18, 2011·BMC Health Services Research·Jeffrey L WintersChester Andrzejewski
Feb 11, 2012·Seminars in Dialysis·Andre Kaplan
Jul 10, 2013·Transfusion Medicine Reviews·E Richard Stiehm
Jun 4, 2014·Journal of Clinical Apheresis·Kelly GwathmeyTed Burns

❮ Previous
Next ❯

Citations

Nov 20, 2015·The Australasian Journal of Dermatology·Danka Svecova
Sep 29, 2018·JAMA Neurology·Nicholas L ZalewskiEoin P Flanagan
Aug 18, 2020·Autoimmune Diseases·Ivana Nieto-AristizábalGabriel J Tobón
Jun 11, 2019·Frontiers in Neurology·Elba Pascual-GoñiEulàlia Turón-Viñas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.